<SEC-DOCUMENT>0001295345-18-000006.txt : 20180215
<SEC-HEADER>0001295345-18-000006.hdr.sgml : 20180215
<ACCEPTANCE-DATETIME>20180215124601
ACCESSION NUMBER:		0001295345-18-000006
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20180215
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
FILED AS OF DATE:		20180215
DATE AS OF CHANGE:		20180215

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Emerald Medical Applications Corp.
		CENTRAL INDEX KEY:			0000797542
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		IRS NUMBER:				680080601
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-15746
		FILM NUMBER:		18616936

	BUSINESS ADDRESS:	
		STREET 1:		7 IMBER STREET
		CITY:			PETACH TIKVA
		STATE:			L3
		ZIP:			4951141
		BUSINESS PHONE:		97237444505

	MAIL ADDRESS:	
		STREET 1:		7 IMBER STREET
		CITY:			PETACH TIKVA
		STATE:			L3
		ZIP:			4951141

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ZAXIS INTERNATIONAL INC
		DATE OF NAME CHANGE:	19950916

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INFERGENE CO
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>mrla8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<html>
<body>

<hr SIZE="4" NOSHADE COLOR="#000000">

<p ALIGN="CENTER"><font FACE="TIMES NEW ROMAN, TIMES, SERIF" SIZE="4"><b>UNITED STATES<br>
SECURITIES AND EXCHANGE COMMISSION<br>
</b></font></p>

<p ALIGN="CENTER"><b><font FACE="TIMES NEW ROMAN, TIMES, SERIF" SIZE="3">Washington, D.C.
20549<br>
</font></b></p>

<p ALIGN="CENTER"><font SIZE="4" FACE="Times New Roman, Times, Serif">___________________<br>
<br>
<strong>FORM 8-K<br>
</strong>___________________</font></p>

<p align="center"><font size="3"><b>CURRENT REPORT</b> </font></p>

<p align="center"><font size="2"><b>Pursuant to Section&nbsp;13 or 15(d) of the Securities
Exchange Act of 1934</b> </font></p>

<p align="center"><font size="2">Date of report (date of earliest event reported):
February 14, 2018</font></p>

<p align="center">&nbsp;</p>

<p ALIGN="CENTER"><font face="TIMES NEW ROMAN, TIMES, SERIF" size="5"><b><u>
<font size="1">

<font size="5">E</font><font size="4">merald </font><font size="5">M</font><font size="4">edical </font><font size="5">
<font size="1" face="TIMES NEW ROMAN, TIMES, SERIF">

<font size="5">A</font><font size="4">pplications </font></font>C</font><font size="4">orp.</font></font></u><br>
</b></font><font face="TIMES NEW ROMAN, TIMES, SERIF" size="1">(Exact Name of Registrant
as Specified in its Charter)</font></p>

<p ALIGN="CENTER"><font size="2">Commission File No.: 0-15476</font></p>

<table border="0" cellpadding="0" cellspacing="0" width="100%">
  <tr>
    <td width="50%" align="center" style="height: 1px"><font FACE="TIMES NEW ROMAN, TIMES, SERIF" SIZE="2"><u>Delaware</u></font></td>
    <td width="50%" align="center" style="height: 1px"><font FACE="TIMES NEW ROMAN, TIMES, SERIF" SIZE="2"><u>68-0080601</u></font></td>
  </tr>
  <tr>
    <td width="50%" align="center" bgcolor="#ffffff" style="height: 1px"><font size="1">(State of Incorporation)</font></td>
    <td width="50%" align="center" bgcolor="#ffffff" style="height: 1px"><font size="1">(I.R.S. Employer
    Identification No.)</font></td>
  </tr>
  <tr>
    <td width="50%" align="center" style="height: 1px"><font size="1">&nbsp; </font></td>
    <td width="50%" align="center" style="height: 1px"><font size="1">&nbsp; </font></td>
  </tr>
  <tr>
    <td width="50%" align="center" style="height: 1px">
	<font FACE="TIMES NEW ROMAN, TIMES, SERIF" SIZE="2"><u>40 Wall Street, 28th
	Floor, NY</u></font></td>
    <td width="50%" align="center" style="height: 1px">
	<font FACE="TIMES NEW ROMAN, TIMES, SERIF" SIZE="2"><u>10005</u></font></td>
  </tr>
  <tr>
    <td width="50%" align="center" bgcolor="#ffffff" style="height: 1px"><font size="1">(Address of Principal
    Executive Offices)</font></td>
    <td width="50%" align="center" bgcolor="#ffffff" style="height: 1px"><font size="1">(ZIP Code)</font></td>
  </tr>
</table>

<p ALIGN="CENTER"><font FACE="TIMES NEW ROMAN, TIMES, SERIF" SIZE="2">Registrant's
Telephone Number, including area code: (212) 400-7198</font></p>

<p><font size="2">Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below): </font></p>

<p><font size="2" FACE="WINGDINGS">&#168</font><font size="2"> Written communications
pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425) <br>
</font><font size="2" FACE="WINGDINGS">&#168</font><font size="2"> Soliciting material
pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)<br>
</font><font size="2" FACE="WINGDINGS">&#168</font><font size="2"> Pre-commencement
communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<br>
</font><font size="2" FACE="WINGDINGS">&#168</font><font size="2"> Pre-commencement
communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
</font></p>


<p Style='page-break-before:always'>

<hr SIZE="2" NOSHADE COLOR="#000000">

	<font size="2" FACE="Times New Roman">
<p align="justify"><b>Item 5.02 Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.</b></p>
<p align="justify">On February 15, 2018, the Board of Directors of Emerald
Medical Applications Corp. (the &quot;Registrant&quot;) received and accepted the letter
of resignation from Mr. Ahmed Alimi, a copy of which is attached as Exhibit
17.10 hereto, resigning as Chief Executive Officer and Chairman of the
Registrant and its wholly-owned Israel subsidiary, Emerald Medical Applications
Ltd (&quot;Emerald Israel&quot;), effective February 14, 2018. Mr. Alimi will continue to
serve as a business development consultant during 2018.</p>
<p align="justify">Mr. Ahmed stated in his letter of resignation that he had no
disagreements with the operations, policies or practices of the Registrant or
Emerald Israel on any matters.</p>
<p align="justify">On February 15, 2018, the Registrant's Board of Directors
appointed Mr. Yair Fudim, as Chairman of the Board of Directors and Chief
Executive Officer of the Registrant. Mr.Fudim previously served as Chairman of
the Registrant's Board of Directors from April 30, 2015 until December 25, 2016,
on which date Mr. Ahmed was appointed as Chairman and CEO. Mr. Fudim continued
to serve as a member of the Registrant's Board of Directors from December 25,
2016 to the present.</p>
<font size="2">

<p ALIGN="JUSTIFY"><strong>Item 9.01 Financial Statements and Exhibits.</strong></p>

<p ALIGN="JUSTIFY">(a) The following documents are filed as exhibits to
this report on Form 8-K or incorporated by reference herein. Any document incorporated by
reference is identified by a parenthetical reference to the SEC filing that included such
document.</p>

<table ALIGN="CENTER" CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="100%" height="0">
  <tr VALIGN="BOTTOM">
    <td height="0" width="8%"><p align="left"><font SIZE="2">Exhibit
    No.</font></td>
    <td height="0" width="92%"><font SIZE="2">Description</font></td>
  </tr>
  <tr>
    <td width="8%" height="0%"><font size="2">17.10</font></td>
    <td width="92%" height="0%"><font size="2">Letter of Resignation of Ahmed
	Alimi dated February 14, 2018, filed herewith.</td>
  </tr>
  <tr>
    <td width="8%" bgcolor="#FFFFFF" height="0%">&nbsp;</td>
  </tr>
	</table>

	</font>

<p style="text-align: center"><font size="2">SIGNATURES</font></p>

<p ALIGN="JUSTIFY"><font size="2">Pursuant to the requirements of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.</font></p>

<table ALIGN="CENTER" CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="100%">
  <tr VALIGN="TOP" BGCOLOR="#66FFFF">
    <td ALIGN="LEFT" WIDTH="100%" bgcolor="#FFFFFF"><div
    STYLE="MARGIN-LEFT: 11px; TEXT-INDENT: -10px"><u><p><i><font
    face="TIMES NEW ROMAN, TIMES, SERIF" size="2">/s/ Yair Fudim</font></i></u><br>
    <font size="2">Chief Executive Officer<br>
    	Yair Fudim<br>
    <i>&nbsp;&nbsp;</i>Date: February 15, 2018</font></p>
    </div></td>
  </tr>
</table>

	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-17
<SEQUENCE>2
<FILENAME>exh17_10.htm
<DESCRIPTION>EXHIBIT 17.10
<TEXT>
<html>
<body>

<p><font size="2">
Exhibit 17.10</font></p>
<p style="text-align: center"><font size="2">
<b>Letter of Resignation</b></p>
<p>Dated: February 14, 2018<br><br>Board of Directors<br>Emerald Medical
Applications Corp.<br><br>Re: Letter of Resignation<br><br>I hereby resign as a
CEO and Chairman of Emerald Medical Applications Corp. (the "Registrant")
effective February 14, 2018. The reason for my resignation is to permit me to
pursue other business interests and opportunities.<br><br>I have had no
disagreements with the operations, policies or practices of the Registrant on
any matters.<br><br>Yours truly,<br><br><br><i>/s/: Ahmed Alimi</i><br>Ahmed Alimi<br>
<br><br></p>

</body>

</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
